Global interest is mounting in advanced biopharmaceutical products. One of the reasons is the emergence of blockbuster drugs in genetic and cell therapies, led by Kymriah, a CAR-T (chimeric antigen receptor T-cell) treatment. Recently, there has been more good news concerning stem cell therapy from
Riding on the new drug-developing zeal among pharmaceutical and biotech companies, CROs (contract research organizations) are attracting attention. A case in point is Dream CIS, which has been moving briskly in recent years.Founded in 2000, Dream CIS was acquired by Hangzhou Tigermed Consulting, the
During the Covid-19 pandemic, the global spotlight naturally gravitated towards vaccine manufacturing technology. As a crucial element of epidemic prevention strategies, vaccines were perceived not merely as pharmaceutical products, but as a symbol of national sovereignty and a formidable defense me
In a bizarre turn of events, the entrance of the Ministry of Food and Drug Safety (MFDS) was adorned with large placards and hundreds of flower wreaths, all cheering on Food and Drug Safety Minister Oh Yu-kyoung.The mastermind behind this unusual sight was none other than Vision Korea, a small share
BOSTON, Mass. -- By Kim Chan-hyuk/Korea Biomedical Review correspondent -- In Korea, known as the cradle of the biosimilar industry with pioneers like Celltrion and Samsung Bioepis, there emerges another notable company making significant strides in the field of antibody-drug R&D. Prestige Biopharma
Korean pharmaceutical and biotechnology companies, including Lotte Biologics and ST Pharm, will search for opportunities to tie up with their French counterparts in the largest U.S. biotech industry fair next week.Business France, a national agency to promote the international growth of the French e
Following Pangyo, Magok, and Songdo, Gwacheon is rapidly emerging as a new biocluster candidate.Korean pharmaceutical companies have recently been gathering in one place to build a Korean-style biocluster, as they can expect synergy effects when R&D personnel and infrastructure are gathered in one p
Samsung Bioepis said that the European Commission (EC) has granted marketing authorization for Epysqli, a biosimilar referencing Soliris (ingredient: eculizumab) for the treatment of adult and children patients with paroxysmal nocturnal hemoglobinuria (PNH).Soliris is a drug developed by Alexion, a
A team of researchers at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) revealed that the smaller the size of microplastics, the greater the accumulation of carcinogens in the body, which can lead to combined toxicity and cause heart deformities.Microplastics (MP) are formed th
Pinotbio, which is jointly developing antibody-drug conjugate (ADC) drugs with Celltrion and Lotte Biologics, has begun developing a manufacturing process for Trop-2-targeted ADCs.Pinotbio said Tuesday that it had been selected as the lead research and development organization for the national task
AriBio said on Tuesday it has signed an agreement to take over the management of Solux, a Kosdaq-listed company. AriBio said in a public filing that its CEO Jung Jae-joon will secure management control of Solux's largest shareholder, CEO Kim Bok-deok, and that Solux will raise 50 billion won ($37.3
Ildong Bioscience said Monday that it participated in Vitafoods Europe 2023 and advertised probiotics-related materials, products, and technology.Vitafoods Europe is the continent’s largest exhibition of healthcare foods, beverages, and functional foods. This year’s event was held in Geneva, Switzer
On Monday, the Korean Advanced Institute of Science and Technology (KAIST) announced that its researchers have identified genomic disruptions in human colorectal epithelial cells, confirming that the activation of L1 retrotransposable or "jumping" genes is linked to aging and carcinogenesis.The acti
Researchers at Kookmin University said Koreans’ birth weight (BW) and gestational period decreased by 3 grams and 0.28 days, respectively, each year for the past 20 years.Professor Hur Yoon-mi of General Education at Kookmin University conducted the study by analyzing Korean birth weight data obtain
Celltrion Healthcare said it won bids to supply its Avastin biosimilar Vegzelma (ingredient: bevacizumab) to Italy and Belgium to treat metastatic colorectal and breast cancer.Most recently, the company won bids in three provinces in Italy -- Lombardy, Emilia Romagna, and Toscana -- in the first qua
Pinotbio, a medical and pharmaceutical developer that attracted investment in partnership with Celltrion and Lotte Biologics, has set about to prepare for its listing on the Kosdaq market.Amid the increasing interest in antibody-drug conjugate (ADC) technology, industry insiders pay attention to whe
The share prices of Bioneer, which drew attention by releasing a shampoo brand that relieves hair loss, plunged on Monday, making investors and analysts curious about its background.Bioneer stocks ended Monday’s trading at 51,300 won ($38.7) a share, down 29.92 percent from 73,200 won the previous t
Celltrion, a Korean biopharma giant, has announced that it will no longer pursue the acquisition of the biopharma solutions unit of Baxter International, a U.S.-based healthcare company.Celltrion has revealed through a public filing on Tuesday that it had contemplated the acquisition of Baxter's bio
Curocell, an immunotherapy developer, is drawing investors’ attention as the company commercializes a domestic CAR-T (chimeric antibody receptor-T cell) therapy and makes a debut on the stock market in the latter half-year.According to the Korea Stock Exchange (KRX), Curocell requested a preliminary
Celltrion said it has signed a joint research and development agreement with Basgen Bio, a big data company, to strengthen its bio data analysis capabilities.Under the contract, the two companies will form a joint research committee and conduct 10 related joint research and development projects over